Intrawound vancomycin powder eradicates surgical wound contamination: an in vivo rabbit study

Lukas P Zebala1, Tapanut Chuntarapas1, Michael P Kelly1

  • 1Departments of Orthopaedic Surgery (L.P.Z., T.C., M.P.K., and K.D.R.) and Comparative Medicine (M.T. and S.G.), Washington University in St. Louis, One Barnes-Jewish Hospital Plaza, Suite 11300 WP, CB 8233, St. Louis, MO 63110. E-mail address for L.P. Zeb.

Abstract

Insights

Intrawound vancomycin powder effectively eliminated Staphylococcus aureus contamination in a rabbit spine surgery model when combined with cefazolin. This animal study supports clinical findings that intrawound vancomycin reduces surgical site infection risk.

Area of Science:

  • Orthopedic Surgery
  • Infectious Disease
  • Pharmacology

Background:

  • Surgical site infections (SSIs) are a significant complication in spine surgery.
  • Prophylactic antibiotics are standard, yet SSIs persist.
  • Previous studies suggest intrawound vancomycin may decrease SSI prevalence.

Purpose of the Study:

  • To evaluate the efficacy of intrawound vancomycin powder in eradicating bacterial contamination in a rabbit spine surgery model.
  • To assess the impact of intrawound vancomycin on Staphylococcus aureus (S. aureus) surgical site contamination.

Main Methods:

  • Twenty rabbits underwent lumbar laminectomy and wire implantation.
  • Surgical sites were inoculated with S. aureus prior to closure.
  • Rabbits received cefazolin; ten also received intrawound vancomycin powder (100 mg).
  • Bacteriologic assessment of tissue and wire samples was performed on postoperative day four.

Main Results:

  • No significant differences in weight or surgery duration between groups.
  • Bacterial cultures were negative in all ten vancomycin-treated rabbits.
  • All ten control rabbits showed persistent S. aureus contamination (p < 0.0001).
  • No sepsis or vancomycin toxicity was observed.

Conclusions:

  • Intrawound vancomycin powder, with preoperative cefazolin, eradicated S. aureus contamination in the rabbit model.
  • Prophylactic cefazolin alone did not prevent S. aureus contamination.
  • Findings support clinical evidence that intrawound vancomycin reduces SSI risk.

Related Concept Videos